Mariana Oncology
Murray Wan has extensive experience in peptide and small molecule drug discovery. Starting as an Undergraduate Research Assistant at the University of Rochester, Murray then progressed to Graduate Research Assistant at Baylor University. Currently, Murray serves as a Principal Scientist at Mariana Oncology, bringing their expertise to peptide RPT drug discovery. Prior to Mariana Oncology, Murray was a Scientist at Merck, honing their skills in small molecule and peptide drug discovery. Murray's educational background includes a Master of Science in Organic Chemistry from Baylor University and a Bachelor's of Science in Organic Chemistry from the University of Rochester.
This person is not in the org chart
Mariana Oncology
1 followers
Mariana Oncology is a fully integrated next generation radiopharmaceutical company that brings together experts in ligand discovery, radiochemistry, radiobiology and oncology translational and clinical research in order to build a pipeline across a range of solid tumor types. Their mission at Mariana is to discover and develop safe, effective, and highly targeted radiopharmaceuticals.